The rising prevalence of breast cancer and the increasing awareness about early detection of the disease are the key factors driving the growth of the market. In addition, the technological advances in breast imaging technologies and the growing investment by public and private organizations are expected to fuel the market growth over the forecast period.However, the high cost of these technologies and the lack of trained professionals are some of the major factors restraining the market growth. Moreover, the side effects associated with radiation exposure are also expected to challenge market growth over the next eight years.The market is segmented based on technology into mammography, ultrasound, MRI, PET/CT, tomosynthesis, and nuclear medicine imaging. Mammography held the largest share of 41.2% in 2016 owing to its wide Acceptance as a screening test for early detection of breast cancer among women above 40 years old. However, ultrasound is anticipated to grow at the highest CAGR of 9.8% from 2017 to 2025 due to its rising popularity as an alternative screening modality for dense breasts which cannot be accurately imaged using mammography alone.Based on application, early detection held the dominant share in 2016 and is projected to grow at CAGR
The cpstest is more likely a timepass game there you can set the highest score and break others record too. Below there are simple steps you need to follow:-
It is just the frequency of clicks to a time unit. It means you increase your frequency of clicks tend to increase your score. While the game is set to default time for 5 seconds, players can switch to other time varieties from the menu on the right sidebar of the page. It includes mainly - clicks per 10 seconds, clicks per 15 seconds, clicks per 30 seconds, clicks per 60 seconds (1 minute), and the giant being click per 100 seconds.
The Cambridge color blindness test for ViSaGe gives a rapid means of screening subjects for color vision deficiencies. It also examines the changes in color discrimination that occur as a result of congenital or acquired conditions.
This test allows the investigator to monitor quantitatively over time the progress or remission of the disease. Many drugs addicted people affected with color vision. The pharmacologist will find the test well fitted to monitoring the short-term or long-term side-effects of the blindness.
The test determines discrimination ellipses in color-deficient subjects by probing chromatic sensitivity along the color confusion lines. Generated Ellipses measured in individuals with even slightly anomalous color vision are characteristically orientated and enlarged.
The Cambridge test is easy to use for people with color blindness people or without blindness people. This test uses a familiar Landolt C stimulus, defined by the two test colors that are to be discriminated, on an achromatic background.
The test uses the fixed concept of introducing spatial and luminance noise into the stimulus, composed of grouped circles randomly varying in diameter and having no spatial structure.
Results are saved in ASCII (American Standard Code For Information Interchange) format and presented graphically as discrimination ellipses in CIELUV or CIE(x,y) color space.
The results are typical of a subject with normal color vision; in deficient subjects, the discrimination ellipses are significantly extended in the protan, deutan or Tritan chromaticity directions.